Inhibrx Biosciences, Inc. ( INBX) - Stock Earnings
INBX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -35.3 million USD | — USD |
| 2025Q4 | -32.8 million USD | — USD |
| 2026Q1 | -33.4 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
INBX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -241.4 million USD | 1.8 million USD |
| 2024 | 1.7 billion USD | 200000 USD |
| 2025 | -140.1 million USD | 1.3 million USD |
| 2026 Est. | — | — |
INBX
Price: $93.51
52 week price:
Earnings Per Share: -8.39 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 275430
Market Capitalization: 1.4 billion